| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/26/2001 | CA2395736A1 Novel nucleic acids and polypeptides |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2394753A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2365610A1 Compositions and methods for the treatment of tumor |
| 07/25/2001 | EP1118679A1 Method for diagnosing polymorphisms in the human PDH E2 gene |
| 07/25/2001 | EP1118669A2 Production of camelid antibodies in plants |
| 07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
| 07/25/2001 | EP1118622A1 Novel antibodies, drugs containing these antibodies and methods for screening compounds by using these antibodies |
| 07/25/2001 | EP1118334A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/25/2001 | EP1118331A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this method |
| 07/25/2001 | EP1117842A1 Methods for selecting prostate cancer treatments and treating prostate cancer |
| 07/25/2001 | EP1117835A1 Prevention of adhesions |
| 07/25/2001 | EP1117833A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
| 07/25/2001 | EP1117803A1 Method for the production of (poly)peptides by using truncated variants of the sv40 large t antigen with an intact n terminus |
| 07/25/2001 | EP1117802A1 Nucleic acid molecules which code a branching enzyme from bacteria of the genus neisseria, and a method for producing alpha-1,6-branched alpha-1,4-glucans |
| 07/25/2001 | EP1117797A2 Rna-associated proteins |
| 07/25/2001 | EP1117796A2 Calcium channel alpha-2/delta gene |
| 07/25/2001 | EP1117793A2 Secretory protein - zsig48 |
| 07/25/2001 | EP1117792A2 Bone marrow-derived serum proteins |
| 07/25/2001 | EP1117791A2 Cancer associated antigens and uses therefor |
| 07/25/2001 | EP1117787A2 Slgp protein and nucleic acid molecule and uses therefor |
| 07/25/2001 | EP1117785A1 Human kinesin-like motor protein |
| 07/25/2001 | EP1117784A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 07/25/2001 | EP1117782A2 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 07/25/2001 | EP1117781A2 Human membrane channel proteins |
| 07/25/2001 | EP1117780A2 Nucleic acids and proteins from cenarchaeum symbiosum |
| 07/25/2001 | EP1117779A1 $i(MORAXELLA CATARRHALIS) PROTEIN, NUCLEIC ACID SEQUENCE AND USES THEREOF |
| 07/25/2001 | EP1117778A2 Methods and compositions for inducing differentiation and apoptosis in cells that overexpress the notch protein |
| 07/25/2001 | EP1117774A1 Method for generating diversity |
| 07/25/2001 | EP1117772A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 07/25/2001 | EP1117767A1 Immunomodulation by genetic modification of dendritic cells and b-cells |
| 07/25/2001 | EP1117692A1 Tie2 agonist antibodies |
| 07/25/2001 | EP1117691A1 Methods for producing human tumor antigen specific antibodies |
| 07/25/2001 | EP1117687A2 Compositions and methods for wt1 specific immunotherapy |
| 07/25/2001 | EP1117682A1 Novel peptides |
| 07/25/2001 | EP1117681A1 Novel peptides |
| 07/25/2001 | EP1117680A2 Ncam binding compounds |
| 07/25/2001 | EP1117675A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 07/25/2001 | EP1117439A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 07/25/2001 | EP1117438A1 Tie2 antagonist antibodies |
| 07/25/2001 | EP1117437A1 Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
| 07/25/2001 | EP1117436A1 Neisseria spp polypeptide, nucleic acid sequence and uses thereof |
| 07/25/2001 | EP1117430A1 Genes differentially expressed in cancer cells to design cancer vaccines |
| 07/25/2001 | EP1117421A2 Methods for therapeutic vaccination |
| 07/25/2001 | EP1117355A1 Targeted therapy to a biomedical device |
| 07/25/2001 | EP0577605B1 G protein-coupled glutamate receptors |
| 07/25/2001 | CN1305527A Vasculogenesis correlation molecule |
| 07/25/2001 | CN1305525A Phagocytic assay method |
| 07/25/2001 | CN1305498A Peptide composition as immunogen for treatment of allergy |
| 07/25/2001 | CN1305497A Monoclonal antibodies directed against the G3BP protein and use |
| 07/25/2001 | CN1305387A Enhancement of antibody-cytokine fusion protein medicated immune responses by co-administration with prostaglandin inhibitor |
| 07/25/2001 | CN1068945C Safety human immunodeficiency virus antibody positiver serum substitute |
| 07/24/2001 | US6265567 Isolated FrpB nucleic acid molecule |
| 07/24/2001 | US6265566 Nucleotide sequences coding plant protein; for diagnosing, treating and preventing allergic responses |
| 07/24/2001 | US6265564 Expressed ligand-vascular intercellular signalling molecule |
| 07/24/2001 | US6265562 Nucleotide sequences coding transcription factor; for the treatment and prevention of infection, tumors, leukemias, autoimmune disease, allergies, arthritis, inflammation, organ rejection, graft versus host disease and coagulation defects |
| 07/24/2001 | US6265560 Nucleotide sequences coding enzymatic polypeptide associated with signal transducton; for diagnosis, prevention, and treatment of inflammation, arthritis and physiological defects |
| 07/24/2001 | US6265556 Nucleotide sequences coding mammalian polypeptide associated with immune response and cell propagation; for the detection of modulators of apoptosis |
| 07/24/2001 | US6265551 Form of dipeptidylpeptidase IV (CD26) found in human serum, antibodies thereto, and uses thereof |
| 07/24/2001 | US6265550 Antibody; for use in the diagnosis, prevention, and treatment of cancer, inflammation, and insulin response defects |
| 07/24/2001 | US6265549 Monoclonal antibody; for use in the treatment of inflammation |
| 07/24/2001 | US6265547 Polypeptide for use in diagnosis, treatment, and prevention of cancer, nervous system disorders |
| 07/24/2001 | US6265545 Reading frame independent epitope tagging |
| 07/24/2001 | US6265544 Adipocyte-specific protein homologs |
| 07/24/2001 | US6265543 Polypeptide for the treatment of eye disorders, tumors, cancer, psoriasis, trauma, psychological, burns and ulcers |
| 07/24/2001 | US6265214 Methods and compositions for inducing monocyte cytotoxicity |
| 07/24/2001 | US6265200 HIV-3 retrovirus and its use |
| 07/24/2001 | US6265195 Nucleic acid of defined nucleotide sequence which codes for a deoxyribonuclease; for production of enough enzyme for clinical use; diagnosis; treatment of cystic fibrosis, lupus, chronic bronchitis, pneumonia, emphysema, and asthma |
| 07/24/2001 | US6265188 Nucleotide sequence coding a enzymatic polypeptide; for use as a wound healing agent; for prevention of bacterial infection |
| 07/24/2001 | US6265184 Polynucleotides encoding chemokine receptor 88C |
| 07/24/2001 | US6265158 Nucleotide sequences associated with genetic disorders; for the detection and diagnosis of preferential genetic disorders |
| 07/24/2001 | US6265150 Phage antibodies |
| 07/24/2001 | US6264958 Polynucleotide |
| 07/24/2001 | US6264955 Ferrichrome transport ATP-binding protein |
| 07/24/2001 | US6264954 Immunogenic peptide |
| 07/24/2001 | US6264953 Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception |
| 07/24/2001 | US6264950 Complex of protein and immunoglobulin |
| 07/24/2001 | US6264948 Methods and compositions for inhibiting tumor cell growth |
| 07/24/2001 | US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents |
| 07/24/2001 | CA2296869A1 A surface-exposed lipoprotein to campylobacter jejuni involved in adherence to hep-2 cells |
| 07/24/2001 | CA2065299C Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 07/19/2001 | WO2001051644A2 ANTI-CD3 SINGLE-CHAIN ANTIBODIES HAVING HUMAN Cν3 AND Cν4 DOMAINS |
| 07/19/2001 | WO2001051642A2 Dna modification proteins |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051636A2 Secreted proteins |
| 07/19/2001 | WO2001051635A2 Novel stra6 polypeptides |
| 07/19/2001 | WO2001051633A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 07/19/2001 | WO2001051629A2 Circularly permutated, interaction-activated proteins |
| 07/19/2001 | WO2001051523A2 Anti-angiogenic proteins and fragments and methods of use thereof |
| 07/19/2001 | WO2001051522A1 Antibodies specific for proteins having polyglutamine expansions |
| 07/19/2001 | WO2001051520A2 Nogo receptor-mediated blockade of axonal growth |
| 07/19/2001 | WO2001051515A2 Genes differentially expressed in breast cancer |
| 07/19/2001 | WO2001051512A2 Human and parasite orphan receptor proteins |
| 07/19/2001 | WO2001051507A1 Novel peptide and screening method by using the same |
| 07/19/2001 | WO2001051086A1 Method to suppress appetite and reduce weight gain by using antibodies directed to a gut peptide such as cholecystokinin |
| 07/19/2001 | WO2001051085A1 Use of antagonists of plasminogen activator inhibitor-1 (pai-1) for the treatment of asthma and chronic obstructive pulmonary disease |
| 07/19/2001 | WO2001051084A1 Diagnosis and treatment of hepatic inflammatory disorders by inhibiting the binding of lfa-1 to icam-1 |
| 07/19/2001 | WO2001051077A1 Methods of regulating il-12 production by administering ccr5 agonists and antagonists |
| 07/19/2001 | WO2001051076A1 ADMINISTERING IgE ANTAGONISTS DURING PREGNANCY TO AMELIORATE ALLERGIC DISEASES IN THE OFFSPRING |
| 07/19/2001 | WO2001014414A3 Human abc2 transporter and uses thereof |